Cytogenetics and its prognostic value in myelodysplastic syndromes

被引：0
|
作者：
Verhoef, GEG
Boogaerts, MA
机构：
来源：
ACTA HAEMATOLOGICA | 1996年 / 95卷 / 02期
关键词：
myelodysplastic syndromes; chromosomes; prognosis; hemopoietic growth factors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review we describe the cytogenetics of primary and secondary myelodysplastic syndromes, discuss their relationship with other hemopoietic malignancies, and also attempt to put the described chromosome abnormalities into a clinically more useful perspective by emphasizing the prognostic impact they carry. In addition, we discuss their use as clonal markers in determining the mode of action and efficiency of different therapeutic approaches.
引用
收藏
页码：95 / 101
页数：7
相关论文
共 50 条
  • [31] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine
    Kamiya, Takahiro
    Nakazato, Tomonori
    MEDICAL ONCOLOGY, 2019, 36 (03)
  • [32] The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes
    Juvonen, E
    Aimolahti, A
    Volin, L
    Ruutu, T
    LEUKEMIA RESEARCH, 1999, 23 (10) : 889 - 894
  • [33] Prognostic value of circulating CD34+ cells in myelodysplastic syndromes
    Cesana, Clara
    Klersy, Catherine
    Brando, Bruno
    Nosari, Annamaria
    Scarpati, Barbara
    Scampini, Linda
    Molteni, Alfredo
    Nador, Guido
    Santoleri, Luca
    Formenti, Marta
    Valentini, Marina
    Mazzone, Antonino
    Morra, Enrica
    Cairoli, Roberto
    LEUKEMIA RESEARCH, 2008, 32 (11) : 1715 - 1723
  • [34] Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes
    Chen, Qiuni
    Chen, Kankan
    Wang, Sumei
    Zhang, Lijuan
    Shi, Yuye
    Tao, Shandong
    He, Zhengmei
    Wang, Chunling
    Yu, Liang
    FRONTIERS IN NUTRITION, 2022, 9
  • [35] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine
    Takahiro Kamiya
    Tomonori Nakazato
    Medical Oncology, 2019, 36
  • [36] Prognostic Markers of Myelodysplastic Syndromes
    Veryaskina, Yuliya Andreevna
    Titov, Sergei Evgenievich
    Kovynev, Igor Borisovich
    Pospelova, Tatiana Ivanovna
    Zhimulev, Igor Fyodorovich
    MEDICINA-LITHUANIA, 2020, 56 (08): : 1 - 16
  • [37] Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes
    Adeyinka, A
    Dewald, GW
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (05) : 1129 - +
  • [38] Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes
    Ohyashiki, K
    Ohyashiki, JH
    Iwabuchi, A
    Toyama, K
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 409 - 415
  • [39] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES
    SANZ, MA
    GARCIA, S
    LORENZO, JI
    AMIGO, V
    LANCET, 1986, 2 (8514): : 1044 - 1044
  • [40] PROGNOSTIC FACTORS IN THE MYELODYSPLASTIC SYNDROMES
    TRICOT, GJ
    LEUKEMIA RESEARCH, 1992, 16 (01) : 109 - 115
12345